Target intelligence / Profile preview

Macrophage phagocytic receptors

Molecular classification
Receptor, Pattern recognition receptor (PRR), C-type lectin receptor (CLR), Scavenger receptor, Immunoglobulin receptor (Fc receptor), Complement receptor
01

Overview

Macrophage phagocytic receptors refer to an array of cell-surface molecules on macrophages that enable recognition and internalization of pathogens, apoptotic cells, and debris via phagocytosis. These include both opsonic (requiring coating of the target, such as Fc receptors for IgG and complement receptors) and non-opsonic (directly recognizing pathogen- or damage-associated molecular patterns) receptors. Major classes are: Toll-like receptors (e.g., TLR2, TLR4, TLR5), central to recognition of bacterial and viral components; Scavenger receptors (e.g., SR-A, MARCO), which bind a variety of polyanionic ligands; C-type lectin receptors (e.g., Dectin-1, Dectin-2, Mincle, MCL, DC-SIGN, Mannose receptor/CD206) important for fungal and glycan recognition; Complement receptors (e.g., CR3/Mac-1), which bind complement-opsonized targets; Fc receptors (e.g., FcγRI/CD64, FcγRII/CD32, FcγRIII/CD16), which bind antibody-opsonized targets. Engagement of these receptors initiates cytoskeletal rearrangement, phagosome formation, and downstream production of inflammatory or anti-inflammatory cytokines, linking innate pathogen clearance to adaptive immune activation. Individual receptor targeting has been explored in therapy and biomarker development, but “macrophage phagocytic receptors” as a whole is too vague and plural to serve as a specific targetable entity. As this is not a single receptor, specific drugs or biologicals may target individual receptors within this group, e.g., antibodies targeting CD206, CD14, or modulating TLRs. Mechanisms are highly receptor specific, e.g., blocking TLR signaling, enhancing phagocytosis through CD206 agonists, etc. Some individual receptors are used as biomarkers, e.g., CD206 for M2 macrophages. Safety issues are tied to targeting specific phagocytic receptors; global modulation of phagocytosis can cause immunodeficiency or excessive inflammation.

Other names
Phagocytic receptors (macrophage)Macrophage phagocytosis receptorsMacrophage opsonic and non-opsonic receptors
02

Biological functions

PhagocytosisImmune responseAntigen presentationClearance of apoptotic cellsPathogen recognition
03

Disease associations

InfectionInflammationCancer (tumor-associated macrophages)Autoimmune diseaseNeurodegenerative disease (impaired clearance)

Beyond the preview

Go deeper on Macrophage phagocytic receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage phagocytic receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call